Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

NCT04847752 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-06-20

No results posted yet for this study

Summary

This is a single-center prospective cohort study of predictive factors related to prognosis of ischemic stroke due to large-artery atherosclerosis.

From March 1, 2021 to December 31, 2026, 1000 patients with ischemic stroke due to large-artery atherosclerosis who are admitted to the Department of Neurology or Neurosurgery, Tongji Hospital are going to be recruited. Detailed clinical data in emergency room and in-hospital will be obtained from the medical record reviews, and the National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) score will be done by certified neurologists to assess the severity of the disease in acute stage and treatment outcome during the follow-up. All cases will undergo routine blood tests, brain magnetic resonance imaging (MRI) and cerebral vascular examination, such as TCD, CTA, HRMR or DSA. The investigators will analyze the in-hospital factors that could predict the outcome to provide more evidence-based suggestions in the treatment and prognosis of atherosclerotic ischemic cerebrovascular disease.

Conditions

Interventions

PROCEDURE

carotid artery stenting

common treatments for carotid artery stenosis

PROCEDURE

carotid endarterectomy

common treatments for carotid artery stenosis

DRUG

Aspirin

the dosage and duration

DRUG

Clopidogrel

the dosage and duration

DRUG

Anticoagulant

the dosage and duration

DRUG

Statin

the dosage and duration

DRUG

PCSK9 inhibitor

the dosage and duration

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Dai-Shi Tian, Dr. · Tongji Hospital

  • Chuan Qin, Dr. · Tongji Hospital

  • Jun Xiao, Dr. · Tongji Hospital

  • Ke Shang, Dr. · Tongji Hospital

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04847752 on ClinicalTrials.gov